| Literature DB >> 18178815 |
Yvonne Burmeister1, Timo Lischke, Anja C Dahler, Hans Werner Mages, Kong-Peng Lam, Anthony J Coyle, Richard A Kroczek, Andreas Hutloff.
Abstract
ICOS is an important regulator of T cell effector function. ICOS-deficient patients as well as knockout mice show severe defects in T cell-dependent B cell responses. Several in vitro and in vivo studies attributed this phenomenon to impaired up-regulation of cell surface communication molecules and cytokine synthesis by ICOS-deficient T cells. However, we now could show with Ag-specific T cells in a murine adoptive transfer system that signaling via ICOS does not significantly affect early T cell activation. Instead, ICOS substantially contributes to the survival and expansion of effector T cells upon local challenge with Ag and adjuvant. Importantly, the observed biological function of ICOS also extends to FoxP3+ regulatory T cells, as can be observed after systemic Ag delivery without adjuvant. In line with these findings, absence of ICOS under homeostatic conditions of nonimmunized mice leads to a reduced number of both effector-memory and FoxP3+ regulatory T cells. Based on these results, we propose a biological role for ICOS as a costimulatory, agonistic molecule for a variety of effector T cells with differing and partly opposing functional roles. This concept may reconcile a number of past in vivo studies with seemingly contradictory results on ICOS function.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18178815 DOI: 10.4049/jimmunol.180.2.774
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422